Clin2
NCT07077018Possibly a fitNot yet recruiting

Fasting-mimicking diet during chemo for hormone-positive breast cancer

Fasting-Mimicking DietBreast CancerNeoadjuvant Chemotherapy

Part of Cancer, Skin clinical trials.

This trial tests whether a special low-calorie diet that mimics fasting can make chemotherapy more effective for people with hormone-receptor-positive breast cancer. If you qualify, you would follow this diet for a few days before and during your chemo cycles.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
45 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You have a type of breast cancer called ER-positive, HER2-negative invasive ductal carcinoma with certain high-risk features.
  • You are between 18 and 75 years old.
  • Your body mass index (BMI) is at least 18.5.
  • Your blood counts and organ function (liver, kidneys) are within a healthy range.
  • You are able to perform daily activities with little to no help (ECOG score 0 to 2).
  • You have not had previous cancer or chemotherapy for this breast cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07378306Recruiting· Phase 2
Fasting-mimicking diet with chemo-immunotherapy for triple-negative breast cancer

This trial tests whether adding a special low-calorie diet (called a fasting-mimicking diet) to standard chemotherapy and immunotherapy can help treat triple-negative breast cancer before surgery. It aims to see if this combination makes the treatment work better.

Guangzhou, Guangdong
NCT06610565Recruiting
Fasting-mimicking diet for breast cancer side effects

This study tests if a special diet that mimics fasting can help reduce side effects from hormone therapy (aromatase inhibitors) in women with breast cancer. The diet is a low-calorie meal plan designed to lower cholesterol and improve well-being.

Milan, Italy
NCT06671613Recruiting
Fasting-mimicking diet with immunotherapy for advanced lung cancer

This study combines a special periodic diet that mimics fasting with the standard immunotherapy drug pembrolizumab (Keytruda) for people with advanced non-small cell lung cancer. The goal is to see if the diet can help the immunotherapy work better.

Long Beach, California
NCT06106477Recruiting
Intermittent fasting for women with early breast cancer

This trial studies whether a 14-hour night fast and 10-hour eating window can improve inflammation markers and quality of life in women with HR+/HER2- early breast cancer. You would start the fasting routine within three months of beginning hormone therapy.

Milwaukee, Wisconsin
NCT06536881Recruiting
Diet and gut health during breast cancer chemo

This study looks at how changing your diet during chemotherapy affects side effects and your body's energy use. It involves providing stool samples to study gut bacteria.

Washington D.C., District of Columbia
NCT05968677Recruiting
Amino acids and flavonoids to reduce chemotherapy side effects

This trial tests whether a specific nutrition supplement (amino acids and flavonoids) can lessen chemotherapy side effects, support nutrition, and improve quality of life in people with non-metastatic breast cancer. It focuses on women who are receiving certain chemotherapy medicines and can eat by mouth and attend regular visits.

Pavia

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.